Levels of Circulating CD34+/KDR+ Cells Do Not Predict Coronary In-Stent Restenosis

Canadian Journal of Cardiology

Volumn 30, Issue 1, 2014, Pages 102-108

  Haine, Steven E ^a,b   Van Craenenbroeck, Emeline M ^a,b   Hoymans, Vicky Y ^a,b   Miljoen, Hielko P ^a,b   Vandendriessche, Tom R ^a,b   Claeys, Marc J ^a,b   Frederix, Geert ^a,b   Conraads, Viviane M ^a,b   Bosmans, Johan M ^a,b   Vrints, Christiaan J ^a,b  

^a ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^b UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; VASCULOTROPIN RECEPTOR 2;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTERY INTIMA PROLIFERATION; ARTICLE; BARE METAL STENT; CELL COUNT; CORONARY STENT; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN-STENT RESTENOSIS; INTRAVASCULAR ULTRASOUND; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NEOINTIMA; PERCUTANEOUS CORONARY INTERVENTION;

EID: 84890839685     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2013.10.012     Document Type: Article

References (29)

1. Cutlip D.E., Chauhan M.S., Baim D.S., et al. Clinical restenosis after coronary stenting: perspectives from multicenter clinical trials. JAm Coll Cardiol 2002, 40:2082-2089.
2. Doyle B., Rihal C.S., O'Sullivan C.J., et al. Outcomes of stent thrombosis and restenosis during extended follow-up of patients treated with bare-metal coronary stents. Circulation 2007, 116:2391-2398.
3. Wijns W., Kolh P., Danchin N., et al. Guidelines on myocardial revascularization. Eur Heart J 2010, 31(20):2501-2555.
4. James S.K., Stenestrand U., Lindback J., et al. Long-term safety and efficacy of drug-eluting versus bare-metal stents in Sweden. NEngl J Med 2009, 360(19):1933-1945.
5. Amin A.P., Spertus J.A., Cohen D.J., et al. Use of drug-eluting stents as a function of predicted benefit: clinical and economic implications of current practice. Arch Intern Med 2012, 172:1145-1152.
6. Yeh R.W., Normand S.L., Wolf R.E., et al. Predicting the restenosis benefit of drug-eluting versus bare-metal stents in percutaneous coronary intervention. Circulation 2011, 124:1557-1564.
7. Asahara T., Murohara T., Sullivan A., et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997, 275:964-967.
8. Kong D., Melo L.G., Gnecchi M., et al. Cytokine-induced mobilization of circulating endothelial progenitor cells enhances repair of injured arteries. Circulation 2004, 110:2039-2046.
9. Yoshioka T., Takahashi M., Shiba Y., et al. Granulocyte colony-stimulating factor (G-CSF) accelerates reendothelialization and reduces neointimal formation after vascular injury in mice. Cardiovasc Res 2006, 70:61-69.
10. Serruys P.W., Foley D.P., Kirkeeide R.L., et al. Restenosis revisited: insights provided by quantitative coronary angiography. Am Heart J 1993, 126:1243-1267.
11. Van Craenenbroeck E.M., Conraads V.M., Van Bockstaele D.R., et al. Quantification of circulating endothelial progenitor cells: a methodological comparison of six flow cytometric approaches. JImmunol Methods 2008, 332:31-40.
12. + stem and progenitor cells by flow cytometry-time to let go!. Cytometry 1998, 34:280-283.
13. Pelliccia F., Cianfrocca C., Rosano G., et al. Role of endothelial progenitor cells in restenosis and progression of coronary atherosclerosis after percutaneous coronary intervention: a prospective study. JACC Cardiovasc Interv 2010, 3:78-86.
14. Werner N., Priller J., Laufs U., et al. Bone marrow-derived progenitor cells modulate vascular re-endothelialization and neointimal formation: effect of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition. Arterioscler Thromb Vasc Biol 2002, 22:1567-1572.
15. Laufs U., Werner N., Link A., et al. Physical training increases endothelial progenitor cells, inhibits neointima formation, and enhances angiogenesis. Circulation 2004, 109:220-226.
16. Kong D., Melo L.G., Mangi A.A., et al. Enhanced inhibition of neointimal hyperplasia by genetically engineered endothelial progenitor cells. Circulation 2004, 109:1769-1775.
17. +) endothelial progenitor cells predicts target lesion revascularization. JThromb Haemost 2012, 10:1906-1913.
18. + endothelial progenitor cells predicts target lesion revascularization: a rebuttal concerning power and sample size calculation. JThromb Haemost 2013, 11:397-398.
19. Kuntz R.E., Baim D.S. Defining coronary restenosis. Newer clinical and angiographic paradigms. Circulation 1993, 88:1310-1323.
20. Mauri L., Orav E.J., Kuntz R.E. Late loss in lumen diameter and binary restenosis for drug-eluting stent comparison. Circulation 2005, 111:3435-3442.
21. Estes M.L., Mund J.A., Mead L.E., et al. Application of polychromatic flow cytometry to identify novel subsets of circulating cells with angiogenic potential. Cytometry A 2010, 77:831-839.
22. Schmidt-Lucke C., Fichtlscherer S., Aicher A., et al. Quantification of circulating endothelial progenitor cells using the modified ISHAGE protocol. PLoS One 2010, 5:e13790.
23. Zhao Y., Glesne D., Huberman E. Ahuman peripheral blood monocyte-derived subset acts as pluripotent stem cells. Proc Natl Acad Sci U S A 2003, 100:2426-2431.
24. Kunz G.A., Liang G., Cuculi F., et al. Circulating endothelial progenitor cells predict coronary artery disease severity. Am Heart J 2006, 152:190-195.
25. Everaert B.R., Van Craenenbroeck E.M., Hoymans V.Y., et al. Current perspective of pathophysiological and interventional effects on endothelial progenitor cell biology: focus on PI3K/AKT/eNOS pathway. Int J Cardiol 2010, 144:350-366.
26. Duckers H.J., Soullie T., den Heijer P., et al. Accelerated vascular repair following percutaneous coronary intervention by capture of endothelial progenitor cells promotes regression of neointimal growth at long term follow-up: final results of the Healing II trial using an endothelial progenitor cell capturing stent (Genous R stent). EuroIntervention 2007, 3:350-358.
27. den Dekker W.K., Houtgraaf J.H., Onuma Y., et al. Final results of the HEALING IIB trial to evaluate a bio-engineered CD34 antibody coated stent (GenousStent) designed to promote vascular healing by capture of circulating endothelial progenitor cells in CAD patients. Atherosclerosis 2011, 219:245-252.
28. van Beusekom H.M., Ertas G., Sorop O., et al. The Genous endothelial progenitor cell capture stent accelerates stent re-endothelialization but does not affect intimal hyperplasia in porcine coronary arteries. Catheter Cardiovasc Interv 2012, 79:231-242.
29. + endothelial progenitor cells in healthy subjects. Relation with lipid profile. JAppl Physiol 2008, 104:1006-1013.